iTeos Therapeutics (ITOS) - Earnings growth in current year
iTeos Therapeutics (ITOS) is actively advancing innovative developments in immuno-oncology, creating cutting-edge methods to combat cancer. The relative annual growth in net income per share reflects current dynamics, with the metric standing at -11.90. Collaboration with GSK ensures financial stability and capital protection, while management effectively allocates resources toward implementing its antibody portfolio into clinical practice.
Comprehensive metric breakdowns and analytics for iTeos Therapeutics (ITOS)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
Total Debt to Capital Coefficient iTeos Therapeutics|ITOS - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio iTeos Therapeutics, Inc.|ITOS - Company Aggregate Debts|Debts to Book Value iTeos Therapeutics, Inc.|ITOS - Company Long-Term Debt|Short-Term Debt iTeos Therapeutics|Interim Coverage Ratio iteostherapeutics.com
- earnings and market ratios statistics:
ITOS - Net Income|Expected Net Income iTeos Therapeutics|ITOS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio iTeos Therapeutics|ITOS - PEG Multiple|Business Value to Operating Income Before Depreciation iTeos Therapeutics|ITOS - Operating profit EBITDA|Net earnings per one share for the last twelve months iTeos Therapeutics|ITOS - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months iteostherapeutics.com|ITOS - Earnings growth in current year|Earnings growth forecast for next year iTeos Therapeutics
- sales volume and revenue information:
Fundamental valuation:ITOS iTeos Pharma
This metric measures the rate of change in earnings per share, reflecting the efficiency of business capitalization relative to the previous year. By analyzing the annual EPS growth profile, an investor can assess the issuer's resilience to market volatility. The metric's dynamics are driven by R&D and commercialization costs for immunotherapy drugs for oncology centers, determining the investment attractiveness of iTeos Therapeutics (ITOS) within the biopharmaceutical sector.
Main competitors
Net earnings per share growth this year argenx SE|Net earnings per share growth this year BNTX|Earnings growth in current year Abivax SA|Earnings per share growth in current year ADMA Bio (ADMA)|Protagonist - Earnings per share growth this year|Earnings growth in current year IMVT (immunovant.com)|Kiniksa Corp (KNSA) - Earnings per share growth rate in current year|Grifols Biemat - Earnings growth in current year|ADPT - Earnings growth in current year|CLDX: Earnings growth in current year|Aurinia Pharmaceuticals Inc (AUPH) - Earnings growth in current year|Earnings per share growth in current year biocryst.com|VERA: Earnings per share increase in current year|Earnings per share growth in current year Dianthus Therapeutics, Inc. (DNTH)|PHVS (Pharvaris) - Earnings per share increase in current year|Earnings per share growth in current year AbCellera ABCL|TRML - Net earnings per share growth this year|Precigen Inc - Earnings growth in current year|Expected net earnings per share growth this year Pharming Corp PHAR|NKTR (Nektar Therapeutics) - Net earnings per share growth this year|Net earnings per share growth this year Upstream Bio|ZBIO (Zenas Bio) - Earnings growth in current year|Earnings per share growth rate in current year Immunome Corp IMNM|Net earnings per share growth this year GOSS (Gossamer Corp)|KALV (KalVista Corp) - Earnings per share increase in current year|Earnings growth in current year SEPN (septerna.com)|Earnings growth in current year pieris.com PVLA|SVRA: Net earnings per share growth this year|Rigel Pharmaceuticals, Inc. (RIGL) - Net earnings per share growth this year|ANAB: Earnings growth in current year|Astria Corp (ATXS) - Earnings growth in current year|Earnings per share growth in current year enGene|Earnings growth in current year RAPT Therapeutics|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings growth in current year KYTX (kyvernatx.com)|TLSA - Net earnings per share growth this year|CABA - Earnings per share growth in current year|Ventyx Biosciences (VTYX) - Net earnings per share growth this year|Theratechnologies, Inc. (THTX) - Earnings per share growth in current year|Net earnings per share growth this year Avalo Therapeutics, Inc.|ELDN (Eledon Pharmaceuticals, Inc) - Earnings growth in current year|Agenus, Inc (AGEN) - Expected net earnings per share growth this year|Earnings growth in current year CLYM|ZURA (Zura Bio Limited) - Earnings per share increase in current year|Earnings per share growth in current year aTyr Pharma ATYR|ADAG - Net earnings per share growth this year|IMA - Earnings per share growth in current year|Shattuck Labs - Net earnings per one share growth for the current year|EQ: Earnings growth in current year|Earnings per share trend in current year CNTB (Connect Biopharma Holdings)|Net earnings per share growth this year IMUX|ATRA (atarabio.com) - Net earnings per one share growth for the current year|Earnings growth in current year IFRX|Earnings growth in current year X4 Pharma (XFOR)|Adicet Bio Inc. - Net earnings per share growth this year|Earnings growth in current year celularity.com CELU|INMB: Net earnings per share growth this year|BRNS: Earnings per share growth in current year|KZR: Earnings growth in current year|SAB Biotherapeutics Inc - Earnings per share increase in current year|AKTX (Akari Therapeutics, Plc) - Earnings growth in current year|ENLV: Earnings per share increase in current year|Earnings per share growth in current year Q32 Bio (QTTB)|Net earnings per share growth this year GeoVax Labs GOVX|Earnings growth in current year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Earnings per share growth rate in current year|CARM: Net earnings per share growth this year|XTL Biopharmaceuticals (XTLB) - Net earnings per share growth this year|BOLT: Earnings growth in current year|Net earnings per share growth this year HCW Biologics Inc.|Earnings per share growth in current year aptevotherapeutics.com|AIM: Earnings per share increase in current year|Earnings per share growth in current year aditxt.com (ADTX)|GRI - Earnings per share growth rate in current year|Earnings growth in current year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Earnings per share growth rate in current year|REVB - Earnings per share growth in current year|INDP - Earnings growth in current year|SCNI: Earnings growth in current year|Net earnings per share growth this year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth in current year|allakos.com (ALLK) - Expected net earnings per share growth this year|Earnings per share growth in current year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per share change in current year|Earnings growth in current year OCEA (oceanbiomedical.com)|Net earnings per one share growth for the current year TCBP (TC Biopharm)|THRD: Net earnings per share growth this year
